 |
|
|
| |
Long-Term Efficacy and Safety of E/C/F/TDF vs. EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected Treatment Naïve Subjects Age ≥ 50 Years
|
| |
| |
Reported by Jules Levin
HIV Drug Therapy Glasgow
Glasgow, UK
November 2-6, 2014
B Gazzard1, PM Girard2, G Di Perri3, J Gallant4, W Towner5, F Rogatto6,
J DeMorin7, D McColl7, HC Liu7, K White7, M Rhee7, J. Szwarcberg7, and D Piontkowsky7
1Chelsea and Westminster Hospital, London, UK; 2Center Hospital at University St Antoine, Paris, France;
3University of Turin School of Medicine, Torino, Italy; 4Southwest CARE Center, Santa Fe, NM; 5Kaiser Permanente, Los Angeles, CA;
6Gilead Sciences Europe Ltd., Stockley Park, UK; 7Gilead Sciences Inc., Foster City, CA
|
| |
|
|
|
|
|
